EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Porphyromonas species in chronic disease: a systematic review of evidence beyond oral infection

Hannah M. Bethel, Arelys A. Angueira-Laureano, Dzifa H. Ameko, Madison R. Marco, Marina R. S. Walther-Antonio

Frontiers in Microbiology · 18.11.2026 · 17

DOI: 10.3389/fmicb.2026.1922292 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Microbiology, online erschienen am 18.11.2026. Verfasst von Hannah M. Bethel und 4 weiteren Autor:innen. Die Arbeit nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porphyromonas has traditionally been regarded as an oral pathogen, yet increasing evidence suggests a broader role in systemic chronic disease. We conducted a systematic review to synthesize evidence linking Porphyromonas species to systemic disease, with particular attention to the predominance of P. gingivalis and emerging evidence for other members of the genus. Five databases (MEDLINE, EMBASE, CENTRAL, CDSR, and Scopus) were searched through June 6, 2025. Following independent screening and data extraction, 194 human, animal, and in vitro studies met the inclusion criteria. Because of substantial heterogeneity, findings were synthesized narratively. Across studies, Porphyromonas species were associated with metabolic, cardiovascular, neurological, inflammatory, gynecologic, and cancer-related diseases. Human studies consistently reported greater detection or abundance of Porphyromonas in diseased tissues compared with healthy controls, while experimental models demonstrated immune dysregulation, inflammatory signaling, epithelial barrier disruption, metabolic alterations, and tissue injury following exposure. P. gingivalis predominated across most disease contexts, whereas species such as P. somerae emerged as potential contributors to gynecologic disease and endometrial cancer. Collectively, the evidence demonstrates associations between Porphyromonas and systemic disease phenotypes in humans, while experimental models provide biological plausibility for potential contributions to disease-related pathways beyond periodontitis. Current evidence is limited by methodological heterogeneity and predominantly observational, detection-based studies, restricting causal inference. Future longitudinal and mechanistic investigations are needed to determine the diagnostic, prognostic, and therapeutic significance of Porphyromonas species in systemic disease.

Zitieren

APA

Bethel, H. M., Angueira-Laureano, A. A., Ameko, D. H., Marco, M. R., & Walther-Antonio, M. R. S. (2026). Porphyromonas species in chronic disease: a systematic review of evidence beyond oral infection. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1922292

Vancouver

Bethel HM, Angueira-Laureano AA, Ameko DH, Marco MR, Walther-Antonio MRS. Porphyromonas species in chronic disease: a systematic review of evidence beyond oral infection. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1922292

BibTeX
@article{Bethel2026,
  author = {Bethel, Hannah M. and Angueira-Laureano, Arelys A. and Ameko, Dzifa H. and Marco, Madison R. and Walther-Antonio, Marina R. S.},
  title = {Porphyromonas species in chronic disease: a systematic review of evidence beyond oral infection},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1922292}
}
Kostenlos starten →